Improved cardiac iodine-123 metaiodobenzylguanidine accumulation after drug therapy in a patient with Parkinson's disease

Clinical Nuclear Medicine

Volumn 22, Issue 10, 1997, Pages 697-699

  Kanzaki, Noriko ^a   Sato, Keiko ^a   Hayabara, Toshiyuki ^a  

^a National Minamiokayama Hospital   (Japan)

Author keywords

Iodine 123 MIBG; Parkinson's Disease

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; PERGOLIDE; THREO 3,4 DIHYDROXYPHENYLSERINE;

AGED; ARTICLE; AUTONOMIC DYSFUNCTION; CASE REPORT; DRUG ACCUMULATION; FEMALE; HEART MUSCLE PERFUSION; HEART SCINTISCANNING; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; PARKINSON DISEASE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREATMENT OUTCOME;

3-IODOBENZYLGUANIDINE; AGED; ANTIPARKINSON AGENTS; AUTONOMIC NERVOUS SYSTEM DISEASES; CORONARY CIRCULATION; DROXIDOPA; FEMALE; FOLLOW-UP STUDIES; GATED BLOOD-POOL IMAGING; HEART; HEART DISEASES; HUMANS; IODINE RADIOISOTOPES; PARKINSON DISEASE; PERGOLIDE; RADIOPHARMACEUTICALS; STROKE VOLUME; SYMPATHETIC NERVOUS SYSTEM; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0031445076     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003072-199710000-00008     Document Type: Article

References (8)

1. Sisson JC, Wieland DM, Sherman P, et al: Metaiodobenzylguanidine as an index of the adrenergic nervous system integrity and function. J Nucl Med 28:1620, 1987.
2. 123I] metaiodobenzylguanidine. Diabetes 41:1069, 1992.
3. Kim SJ, Lee JD, Ryu YH, et al: Evaluation of cardiac sympathetic neuronal integrity in diabetic patients using iodine-123 metaiodobenzylguanidine. Eur J Nucl Med 23:401, 1996.
4. Sisson JC, Shapiro B, Meyers L, et al: Metaiodobenzylguanidine to map scintigraphically the adrenergic nervous system in man. J Nucl Med 28:1625, 1987.
5. 123I] iodobenzylguani- dine in neurological patients with autonomic failure. J Auton Nerv Syst 49:81, 1994.
6. Kato T, Karai N, Katsuyama M, et al: Studies on the activity of L-threo-3,4-dihydroxyphenylserine(L-DOPS) as a catechol- amine precursor in the brain: comparison with that of L-DOPA. Biochem Pharmacol 36:3051, 1987.
7. Langtry HD, Clissold SP: Pergolide: A review of pharmacological properties and therapeutic potential in Parkinson's disease. Drugs 39:491, 1990.
8. Solanki KK, Bomanji J, Moyes J, et al: A pharmacological guide to medicines which interfere with the biodistribution of radiolabelled meta-iodobenzylguanidine (MIBG). Nucl Med Commun 13:513, 1992.